Quotation in Aptinyx will resume at 4:30pm E.T., acc Shares have been halted ahead of the company’s announcement that its Phase 2 Study of NYX-458 did not demonstrate sufficient efficacy in patients with cognitive impairment associated with Parkinson’s disease and dementia with Lewy bodies.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on APTX: